Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Ablation of severe drug-resistant tachyarrhythmia during pregnancy|
|Citation:||Journal of Cardiovascular Electrophysiology, 2010; 21(8):877-882|
|Publisher:||Futura Publ Co|
|Lukasz Szumowski, Ewa Szufladowicz, Michał Orczykowski, Robert Bodalski, Paweł Derejko, Andrzej Przybylski, Piotr Urbanek, Mariusz Ku´Smierczyk, Edward Ko´Zluk, Frederic Sacher, Prashanthan Sanders, Joanna Dangel, Michel Haissaguerre, and Franciszek Walczak|
|Abstract:||<h4>Aims</h4>The goal of this study was to describe mapping and ablation of severe arrhythmias during pregnancy, with minimum or no X-ray exposure. Treatment of tachyarrhythmia in pregnancy is a clinical problem. Pharmacotherapy entails a risk of adverse effects and is unsuccessful in some patients. Radiofrequency ablation has been performed rarely, because of fetal X-ray exposure and potential maternal and fetus complications. GROUP AND METHOD: Mapping and ablation was performed in 9 women (age 24-34 years) at 12-38th week of pregnancy. Three had permanent junctional reciprocating tachycardia, and 2 had incessant atrial tachycardia. Four of them had left ventricular ejection fraction < or =45%. One patient had atrioventricular nodal reciprocating tachycardia requiring cardioversion. Three patients had Wolff-Parkinson-White syndrome. Two of them had atrial fibrillation with ventricular rate 300 bpm and 1 had atrioventricular tachycardia 300 bpm. Fetal echocardiography was performed before and after the procedure.<h4>Results</h4>Three women had an electroanatomic map and ablation done without X-ray exposure. The mean fluoroscopy time in the whole group was 42 +/- 37 seconds. The mean procedure time was 56 +/- 18 minutes. After the procedure, all women and fetuses were in good condition. After a mean period of 43 +/- 23 months follow up (FU), all patients were free of arrhythmia without complications related to ablation either in the mothers or children.<h4>Conclusion</h4>Ablation can be performed safely with no or minimal radiation exposure during pregnancy. In the setting of malignant, drug-resistant arrhythmia, ablation may be considered a therapeutic option in selected cases.|
|Keywords:||ablation; atrioventricular (AV) node reentry; fluoroscopy; pregnancy; supraventricular tachycardia; Wolff-Parkinson-White syndrome|
|Rights:||© 2010 Wiley Periodicals, Inc.|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.